- Comprehensive analysis and establishment of a prognostic model based on non-genetic predictors in multiple myeloma (vol 38, pg 49, 2023)Lu, Weiguo; Xu, Shumin; Tan, Sui; Lu, Lu; Luo, Man; Xiao, Mingfeng*Cancer Biomarkers, 2023, 38(3): 411-411.
- FABP4 Suppresses the Progress of Multiple Myeloma through Enhancing Alarming Function of Bone Marrow Resident Memory T LymphocytesZhu, Ziang; Li, Yang; Huang, Han-Ying; Chen Shuzhao; Liu, Yang; Liang, Yang; Shu, Lingling65th Annual Meeting of the American-Society-of-Hematology (ASH), San Diego, CA, 2023-12-09 To 2023-12-12.
- CRIP1 Upregulated Along with chr1q-Gain Indicates Immune Dysregulation and Portends Poor Outcomes in Multiple MyelomaZhang, Shanshan; Cai, Linjing; Zhang Hanzhen; Wang, Yuqi; Huan, Chen; Wei, Xiaolei; Liu, Qifa65th Annual Meeting of the American-Society-of-Hematology (ASH), San Diego, CA, 2023-12-09 To 2023-12-12.
会议论文
CD43 Expression Is an Adverse Prognostic Factor in Newly Diagnosed Multiple Myeloma
1被引16阅读
